Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

1(20%)

Results Posted

67%(2 trials)

Phase Distribution

Ph not_applicable

80%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

N/ANon-phased studies

4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Other(1)

Detailed Status

Completed3

Suspended1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

suspended120%

recruiting120%

completed360%

Recent Activity

1 active trials

Showing 5 of 5

recruitingnot_applicable

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

NCT06310031

suspendednot_applicable

Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System

NCT01187368

completed

Clinical Trials (5)

Showing 5 of 5 trials

NCT06310031Not Applicable

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Recruiting

NCT01187368Not Applicable

Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System

Suspended

NCT02497950

HeartMate 3 ELEVATE™ Registry

Completed

NCT04974684Not Applicable

DOT HeartMate 3 Study

Completed

NCT02475460Not Applicable

HeartMate 3™ LIS Study

Completed

All 5 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 5